相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
Oscar Arrieta et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Racial Diversity of Actionable Mutations in Non-Small Cell Lung Cancer
Aliccia Bollig-Fischer et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
EGFR Mutations in US Hispanic Versus Non-Hispanic White Patients With Lung Adenocarcinoma
Wei Zhang et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
Yuankai Shi et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice
Norihiro Yamaguchi et al.
LUNG CANCER (2013)
Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist?
Joshua Bauml et al.
LUNG CANCER (2013)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans with Non-small Cell Lung Cancer
Michele L. Cote et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans
J. Matthew Reinersman et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America
Oscar Arrieta et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Genetic Abnormalities of the EGFR Pathway in African American Patients With Non-Small-Cell Lung Cancer
Rom S. Leidner et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese
Keitaro Matsuo et al.
CANCER SCIENCE (2007)
Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors
Emiliano Calvo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Participation in cancer clinical trials - Race-, sex-, and age-based disparities
VH Murthy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
